Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Jan 29, 2021 10:21am
178 Views
Post# 32419525

NEWCAMO IGNORANT

NEWCAMO IGNORANTCAMO, I put all your aliases on ignore and you are close to be the next. You are ignorant and you still try to mislead people.

Ryplazim will never be approuved with Liminal. They decided to get rid of the plasma division because they don't have the staff and the money to produce Ryplazim anymore. The VP production in Laval (Harris) is not working for LIminal anymore and they can't be helped by the Maryland staff who were involved in PPPS technology still de begeening.

Would you beleive that FDA wants new batch test before approuval?  They are unable to produce it. They also can't make M&A because they want partners who wil produce, market, technicaly support the product and willing to pay big money. A dream!

If I'm wrong tell them to do a press release NOW
<< Previous
Bullboard Posts
Next >>